BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Wyeth Biotech (Massachusetts) 

One Burtt Road

Andover  Massachusetts  01810  U.S.A.
Phone: 978-475-9214 Fax:


View Clinical Trials from BioPharm Insight

The Andover campus is part of Wyeth Biotech, the organization within Wyeth Pharmaceuticals dedicated to the successful development and manufacturing of recombinant protein biopharmaceuticals. Located in the heart of the Merrimack Valley, it is home to leading experts in development and commercialization of human pharmaceuticals through recombinant DNA and other technologies. This group is positioned to secure the tremendous global market potential for biopharmaceutical products.

The Andover campus is one of the largest biopharmaceutical operations in the United States. Nearly 1,900 scientists, engineers, technicians and other biopharmaceutical professionals work in this team-based environment to develop production processes, analytical methods and products and to manufacture and control products for clinical trials and for global markets. The company vision "to lead the way to a healthier world" has fueled a collaborative work environment dedicated to creating the preeminent biopharmaceutical company. Wyeth Biotech is fusing leading-edge science with the development and manufacturing of breakthrough recombinant protein therapeutics. This commitment to improve life by advancing science has led to and continues to produce a strong diversified product pipeline for therapeutics in treatment areas such as anemia, hemophilia, cancer, bone damage, inflammatory conditions, and immune system disorders.

Career Information:
Lead the way to a better career with Wyeth Biotech

Wyeth Pharmaceuticals is the pharmaceutical division of Wyeth (NYSE: WYE).

 Key Statistics

Ownership: Subsidiary

Web Site: Wyeth Biotech (Massachusetts)
Employees: 1900
Symbol: WYE


 Company News
First Prempro Suit Goes To Trial In Ark.T 8/21/2006 8:27:05 AM
BioSpace, Inc. And Massachusetts Biotechnology Council, Inc. Unveil 2006 Genetown™ Campaign 12/14/2005 6:22:26 PM
Wyeth-Vaccines Researchers Honored By Pharmaceutical Industry10/19/2005 5:13:07 PM
Wyeth (WYE) Comments On Earnings Guidance For 2005 First Quarter; Addresses Analyst Estimates10/19/2005 5:13:05 PM
Wyeth (WYE) To Present At The SG Cowen & Co., LLC 25th Annual Healthcare Conference10/19/2005 5:13:00 PM
Wyeth Pharmaceuticals (WYE) To Add 52 New Biotech Jobs In Massachusetts10/19/2005 5:12:35 PM
BioSpace Celebrates A Decade Of Genetown™10/19/2005 5:12:28 PM
UK Tightens Antidepressant Rules, Curbs Wyeth Drug10/19/2005 5:12:22 PM
Philadelphia Trial Results In Split Verdict; Wyeth (WYE) Prevails In One Case, While Jury Awards $41,000 In Compensatory Damages In Second Case 10/19/2005 5:11:55 PM
Wyeth (WYE) To Present At The Deutsche Bank Annual Health Care Conference10/19/2005 5:10:41 PM